Onconova Therapeutics Inc ONTX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:51 PM EDT
1.29quote price arrow down-0.01 (-0.39%)
Volume
2,352
Close
1.29quote price arrow down-0.02 (-1.89%)
Volume
28,607
52 week range
1.00 - 7.08
Loading...
  • Open1.32
  • Day High1.32
  • Day Low1.29
  • Prev Close1.32
  • 52 Week High7.08
  • 52 Week High Date07/01/21
  • 52 Week Low1.00
  • 52 Week Low Date05/12/22

Key Stats

  • Market Cap27.07M
  • Shares Out20.90M
  • 10 Day Average Volume0.07M
  • Dividend-
  • Dividend Yield-
  • Beta1.62
  • YTD % Change-49.22

KEY STATS

  • Open1.32
  • Day High1.32
  • Day Low1.29
  • Prev Close1.32
  • 52 Week High7.08
  • 52 Week High Date07/01/21
  • 52 Week Low1.00
  • 52 Week Low Date05/12/22
  • Market Cap27.07M
  • Shares Out20.90M
  • 10 Day Average Volume0.07M
  • Dividend-
  • Dividend Yield-
  • Beta1.62
  • YTD % Change-49.22

RATIOS/PROFITABILITY

  • EPS (TTM)-0.86
  • P/E (TTM)-1.50
  • Fwd P/E (NTM)-1.47
  • EBITDA (TTM)-16.516M
  • ROE (TTM)-39.20%
  • Revenue (TTM)230,000.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-6,889.38%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date08/10/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Onconova Therapeutics Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Onconova Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which is focused on discovering and developing products for patients with cancer. It has molecularly targeted agents designed to disrupt specific cellular pathways for cancer cell proliferation. It has the two clinical-stage programs: narazaciclib (ON 123300), which is a multi-targeted kinase inhibitor in solid tumors and hematological malignancies as a single agent or in combination with other...
James Marino
Independent Chairman of the Board
Steven Fruchtman M.D.
President, Chief Executive Officer, Director
Mark Guerin
Chief Financial Officer, Chief Operating Officer
Address
375 Pheasant Run
Newtown, PA
18940
United States